Literature DB >> 18521270

Oncogenic osteomalacia as a harbinger of recurrent osteosarcoma.

E B Lamont1, M K Cavaghan, B E Brockstein.   

Abstract

Discussion. Oncogenic osteomalacia is a rare paraneoplastic syndrome of skeletal demineralization from renal phosphate loss. Patients with this disorder have the characteristic clinical, laboratory, and radiographic findings of hyperphosphaturic osteomalacia. Although the pathophysiology has not yet been clearly delineated, a humoral factor produced by the tumor is suspected to be the cause.Purpose. We report the first case of oncogenic osteomalacia that improved with chemotherapy, discuss this paraneoplastic syndrome, and review the medical literature regarding its etiology.

Entities:  

Year:  1999        PMID: 18521270      PMCID: PMC2395412          DOI: 10.1080/13577149977712

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  8 in total

1.  Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.

Authors:  Q Cai; S F Hodgson; P C Kao; V A Lennon; G G Klee; A R Zinsmiester; R Kumar
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

2.  Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients.

Authors:  R Rossi; A Gödde; A Kleinebrand; M Riepenhausen; J Boos; J Ritter; H Jürgens
Journal:  J Clin Oncol       Date:  1994-01       Impact factor: 44.544

3.  Characteristics of tumor cell bioactivity in oncogenic osteomalacia.

Authors:  A E Nelson; H J Namkung; J Patava; M R Wilkinson; A C Chang; R R Reddel; B G Robinson; R S Mason
Journal:  Mol Cell Endocrinol       Date:  1996-11-29       Impact factor: 4.102

4.  Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions.

Authors:  L C Aschinberg; L M Solomon; P M Zeis; P Justice; I M Rosenthal
Journal:  J Pediatr       Date:  1977-07       Impact factor: 4.406

5.  Parathyroid hormone-like bioactivity in tumours from patients with oncogenic osteomalacia.

Authors:  M S Seshadri; C J Cornish; R S Mason; S Posen
Journal:  Clin Endocrinol (Oxf)       Date:  1985-12       Impact factor: 3.478

6.  A neuroendocrine cause of oncogenic osteomalacia.

Authors:  M D Stone; C Quincey; D J Hosking
Journal:  J Pathol       Date:  1992-06       Impact factor: 7.996

7.  Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.

Authors:  A Miyauchi; M Fukase; M Tsutsumi; T Fujita
Journal:  J Clin Endocrinol Metab       Date:  1988-07       Impact factor: 5.958

8.  Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.

Authors:  G E Wilkins; S Granleese; R G Hegele; J Holden; D W Anderson; G P Bondy
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

  8 in total
  6 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

Review 2.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14

3.  Oncogenic osteomalacia: Problems in diagnosis and long-term management.

Authors:  Ish K Dhammi; Anil K Jain; Ajay Pal Singh; Puneet Mishra; Saurabh Jain
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

4.  Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells.

Authors:  Rama Garimella; Priyanka Tadikonda; Ossama Tawfik; Sumedha Gunewardena; Peter Rowe; Peter Van Veldhuizen
Journal:  Int J Mol Sci       Date:  2017-03-16       Impact factor: 5.923

Review 5.  Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review.

Authors:  Huanwen Wu; Marilyn M Bui; Lian Zhou; Dongmei Li; Hui Zhang; Dingrong Zhong
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

6.  Tumour-induced Osteomalacia Secondary to a Sarcoma.

Authors:  Karla Victoria Rodriguez-Velver; María Azucena Zapata-Rivera; Juan Montes-Villarreal; Fernando Javier Lavalle-Gonzâlez; José Gerardo González-González; Jesús Zacarías Villarreal-Pérez; Rene Rodríguez-Gutierrez
Journal:  Eur Endocrinol       Date:  2016-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.